structural variant analysis

The OSUCCC researchers plan to prospectively study how well patients with PD-L1/2 structural variants do on anti-PD-1 therapy and are seeking pharma partners for that effort.

Researchers profiled structural variant patterns in 179 pediatric high-grade glioma cases, identifying SV features linked to tumor subtypes and clinical outcomes.

A structural variant analysis based on genome sequences for almost 800 multiple myeloma cases suggests a IgL translocation present in nearly 10 percent of patients may inform survival.